Strides Pharma Science Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 568.08 | 553.35 | 543.10 |
| Operating Expense | 488.03 | 476.84 | 464.19 |
| Net Profit | 16.13 | 14.94 | 17.26 |
| Net Profit Margin | 2.84 | 2.70 | 3.18 |
| Earning Per Share | 1.75 | 1.62 | 1.88 |
| EBIDTA | 62.62 | 75.81 | 76.77 |
| Effective Tax Rate | -6.55 | 7.50 | -3.83 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 568.08 |
| Operating Expense | 488.03 |
| Net Profit | 16.13 |
| Net Profit Margin | 2.84 |
| Earning Per Share | 1.75 |
| EBIDTA | 62.62 |
| Effective Tax Rate | -6.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2,139.42 | 1,866.12 | 1,854.50 |
| Operating Expenses Annual | 1,876.98 | 1,715.61 | 1,756.02 |
| Operating Profit Annual | 3,135.66 | 272.68 | 167.54 |
| Interest Annual | 145.91 | 139.38 | 138.68 |
| Depreciation | 76.75 | 84.09 | 81.71 |
| Net Profit Annual | 59.16 | -24.28 | 4.68 |
| Tax Annual | 18.93 | 1.34 | -69.44 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2,139.42 |
| Operating Expenses Annual | 1,876.98 |
| Operating Profit Annual | 3,135.66 |
| Interest Annual | 145.91 |
| Depreciation | 76.75 |
| Net Profit Annual | 59.16 |
| Tax Annual | 18.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 92.75 | 82.11 | 12.12 |
| Cash Flow from Operations | 421.48 | -14.01 | 241.74 |
| Cash Flow from Investing | -137.59 | -68.69 | -182.58 |
| Cash Flow from Financing | -370.32 | 93.34 | 10.82 |
| Cash Flow at the End | 6.33 | 92.75 | 82.11 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 92.75 |
| Cash Flow from Operations | 421.48 |
| Cash Flow from Investing | -137.59 |
| Cash Flow from Financing | -370.32 |
| Cash Flow at the End | 6.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 14.43 | 11.23 | 9.91 |
| PBIT Margin (%) | 10.48 | 6.55 | 4.87 |
| PBT Margin (%) | 10.41 | 6.50 | 4.83 |
| Net PROFIT Margin (%) | 134.91 | 2.39 | 0.25 |
| Return On Networth / Equity (%) | 85.90 | 1.43 | 0.61 |
| Return On Networth /Employed (%) | 4.62 | 2.40 | 1.87 |
| Return On Assets (%) | 59.36 | 0.88 | 0.10 |
| Total Debt / Equity (X) | 0.43 | 0.44 | 0.39 |
| Asset Turnover Ratio (%) | 0.44 | 0.37 | 0.39 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 14.43 |
| PBIT Margin (%) | 10.48 |
| PBT Margin (%) | 10.41 |
| Net PROFIT Margin (%) | 134.91 |
| Return On Networth / Equity (%) | 85.90 |
| Return On Networth /Employed (%) | 4.62 |
| Return On Assets (%) | 59.36 |
| Total Debt / Equity (X) | 0.43 |
| Asset Turnover Ratio (%) | 0.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 795.96 | 771.89 | 623.89 |
| Total Current Assets Annual | 2,145.50 | 2,411.18 | 2,126.40 |
| Non Current Assets Annual | 2,885.44 | 3,490.70 | 3,493.34 |
| Total Shareholders Funds Annual | 3,192.74 | 3,527.60 | 3,455.05 |
| Total Assets Annual | 5,030.95 | 5,901.87 | 5,619.74 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 795.96 |
| Total Current Assets Annual | 2,145.50 |
| Non Current Assets Annual | 2,885.44 |
| Total Shareholders Funds Annual | 3,192.74 |
| Total Assets Annual | 5,030.95 |
EPS (INR)
Expected
8.92
Reported
8.92
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.21%
Jun 2024
EPS beaten by 0.00%
